Drug Approval

Drugs Fast-Tracked by FDA Linked to Increased Safety-Label Changes After Approval

Drugs Fast-Tracked by FDA Linked to Increased Safety-Label Changes After Approval

By

Drugs that receive accelerated approval status from the FDA are associated with increased safety-related label changes after approval.

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

FDA Approves Duzallo, Lesinurad Plus Allopurinol Combo Drug, for Gout

By

The FDA approved Duzallo, a fixed-dose tablet combining lesinurad and allopurinol, for the treatment of uncontrolled gout.

Sign Up for Free e-Newsletters